Biomatter

Custom enzyme design company using AI-powered design to create novel enzymes from the chemistry up biomatter.ai

Funding

• $18 million Series A, announced November 12, 2026. Led by Astanor. Oversubscribed round. Existing investors UVC Partners, Inventure and Metaplanet participated. Listed in the AI startup funding roster for November 8–14, 2026. Sources: Biomatter announcement, Tech.eu.

Of the 90 Series A rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, Biomatter's $18 million is the joint 57th largest; their median is $20.85 million.

Whether AI names Biomatter

• Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 14, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

Related records

Closest rounds in the roster for November 8–14, 2026: XpertDox ($20 million Series A, November 11, 2026), WhiteMatter ($20 million Series A, November 10, 2026), Nebuly ($21 million Series A, November 12, 2026), 4Minds ($15 million Series A, November 11, 2026), Hatz AI ($24 million Series A, November 12, 2026), Luminal ($25 million Series A, November 12, 2026).

Sources

• Biomatter announcement
• Tech.eu

Every fact on this page links its source. Corrections need a public source: see Contact.